Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolly Aguilera

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Pediatric Blood & Cancer|March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing ApproachPatricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline GliomaIsabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Neuro-Oncology|September 16, 2023
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trialTheodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort StudyCraig Erker, Martin Mynarek, Simon Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Pediatric Blood & Cancer|March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing ApproachPatricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline GliomaIsabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Neuro-Oncology|September 16, 2023
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trialTheodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort StudyCraig Erker, Martin Mynarek, Simon Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 3